Cingulate Inc. Company Profile
Cingulate Inc. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 1901 W. 47TH PLACE, KANSAS CITY, Kansas, 66205, United States.
- Mailing address: Value 1901 W. 47TH PLACE, KANSAS CITY, Kansas, 66205, United States.
| Measure | Value |
|---|---|
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 1901 W. 47TH PLACE, KANSAS CITY, Kansas, 66205, United States |
| Mailing address | 1901 W. 47TH PLACE, KANSAS CITY, Kansas, 66205, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| Listed stock (Section 12(b)) | Common Stock, par value
$0.0001 per share · CING · NASDAQ 10-Q filed 2026-08-13 cover |
| Shell company | No 10-Q filed 2026-08-13 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-13 cover |
| Emerging growth company | Yes 10-Q filed 2026-08-13 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-13 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-18 cover |
| Voluntary filer | No 10-K filed 2026-03-18 cover |
| Former names | Cingulate Inc. (2021-05-24 to 2026-08-13) |
| First EDGAR filing | 2021-05-24 (DRS) |
| SEC CIK | 1862150 |
| EIN | 863825535 |
| Phone | (913) 942-2300 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |